The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nexium 20 mg gastro-resistant tablets

20 milligram(s) Gastro-resistant tablet

Lexon (UK) LtdPPA1097/031/001

Main Information

Trade NameNexium 20 mg gastro-resistant tablets
Active SubstancesEsomeprazole
Strength20 milligram(s)
Dosage FormGastro-resistant tablet
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/031/001

Group Information

ATC CodeA02BC Proton pump inhibitors
A02BC05 esomeprazole

Status

Authorised/WithdrawnAuthorised
Licence Issued27/10/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0970/027/001.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0004-003-016
Interchangeable List DocumentPDF of Interchangeable List
« Back